newsfilter
← Latest News
GlobeNewswire·

argenx to Host Myositis R&D Webinar on June 23, 2026

May 28, 2026Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will